Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""101568867"" wg kryterium: JN


Tytuł :
Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with esophageal cancer.
Autorzy :
Yang XL; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, China.; State Key Laboratory of Bio-Control, School of Life Sciences, Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Sun Yat-sen University, University City, Guangzhou, China.
Wang P; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, China.; Henan Key Laboratory of Tumor Epidemiology and College of Public Health, Zhengzhou University, Zhengzhou, China.
Ye H; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, China.; Henan Key Laboratory of Tumor Epidemiology and College of Public Health, Zhengzhou University, Zhengzhou, China.
Jiang M; State Key Laboratory of Bio-Control, School of Life Sciences, Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Sun Yat-sen University, University City, Guangzhou, China.
Su YB; Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Department of Biotechnology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Peng XX; State Key Laboratory of Bio-Control, School of Life Sciences, Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Sun Yat-sen University, University City, Guangzhou, China.
Li H; State Key Laboratory of Bio-Control, School of Life Sciences, Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Sun Yat-sen University, University City, Guangzhou, China.
Zhang JY; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, China.; Henan Academy of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 938234. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A detection panel of novel methylated DNA markers for malignant pleural effusion.
Autorzy :
Liang C; Department of Cardio-Pulmonary Function, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, Henan, China.; Department of Pulmonary and Critical Care Medicine, The First Hospital of China Medical University, Shenyang, China.
Liu N; Department of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
Zhang Q; Department of Pulmonary and Critical Care Medicine, The First Hospital of China Medical University, Shenyang, China.
Deng M; Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, National Center of Respiratory Medicine, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, National Clinical Research Center for Respiratory Diseases, Beijing, China.
Ma J; Department of Pulmonary and Critical Care Medicine, The First Hospital of China Medical University, Shenyang, China.
Lu J; Department of Pulmonary and Critical Care Medicine, The First Hospital of China Medical University, Shenyang, China.
Yin Y; Department of Pulmonary and Critical Care Medicine, The First Hospital of China Medical University, Shenyang, China.
Wang J; Department of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
Miao Y; Department of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
She B; Academic Development, Tellgen Corporation, Shanghai, China.
Li Q; Department of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
Hou G; Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, National Center of Respiratory Medicine, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, National Clinical Research Center for Respiratory Diseases, Beijing, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 967079. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Feasibility of hepatocellular carcinoma treatment based on the tumor microenvironment.
Autorzy :
Wang H; Department of Internal Medicine, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
Shi F; Graduate School of Heilongjiang University of Chinese Medicine, Harbin, China.
Zheng S; Graduate School of Heilongjiang University of Chinese Medicine, Harbin, China.
Zhao M; Graduate School of Heilongjiang University of Chinese Medicine, Harbin, China.
Pan Z; Graduate School of Heilongjiang University of Chinese Medicine, Harbin, China.
Xiong L; Graduate School of Heilongjiang University of Chinese Medicine, Harbin, China.
Zheng L; Department of Internal Medicine, Fourth Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 896662. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Evaluation of the efficacy of transcatheter arterial embolization combined with apatinib on rabbit VX2 liver tumors by intravoxel incoherent motion diffusion-weighted MR imaging.
Autorzy :
Chen C; Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China.
Liu X; Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China.
Deng L; Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China.
Liao Y; Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China.
Liu S; Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China.; Teaching and Research Section of Imaging and Nuclear Medicine, The Third Xiangya Hospital, Central South University, Changsha, China.
Hu P; Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China.
Liang Q; Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 951587. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A pan-cancer analysis of the expression of STAT family genes in tumors and their relationship to the tumor microenvironment.
Autorzy :
Zhou M; Department of Breast Surgery, The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, Wuxi, China.
Zhang P; Department of Breast Surgery, The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, Wuxi, China.
Da M; Breast Disease Diagnosis and Treatment Center, Affiliated Hospital of Qinghai University and Affiliated Cancer Hospital of Qinghai University, Xining, China.
Yang R; Research Institute for Reproductive Health and Genetic Diseases, The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, Wuxi, China.
Ma Y; Department of Obstetrics and Gynecology, Haidong No.2 People's Hospital of Qinghai Province, Haidong, China.
Zhao J; Breast Disease Diagnosis and Treatment Center, Affiliated Hospital of Qinghai University and Affiliated Cancer Hospital of Qinghai University, Xining, China.
Ma T; Department of Breast Surgery, The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, Wuxi, China.
Xia J; Department of General Surgery and Translational Medicine Center, The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi, China.
Shen G; Breast Disease Diagnosis and Treatment Center, Affiliated Hospital of Qinghai University and Affiliated Cancer Hospital of Qinghai University, Xining, China.
Chen Y; Research Institute for Reproductive Health and Genetic Diseases, The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, Wuxi, China.
Chen D; Department of Breast Surgery, The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, Wuxi, China.; Research Institute for Reproductive Health and Genetic Diseases, The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, Wuxi, China.; Department of Obstetrics and Gynecology, Haidong No.2 People's Hospital of Qinghai Province, Haidong, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 925537. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Clinical prediction model based on 18F-FDG PET/CT plus contrast-enhanced MRI for axillary lymph node macrometastasis.
Autorzy :
Kawaguchi S; Breast and Endocrine Surgery, Toranomon Hospital, Tokyo, Japan.
Tamura N; Breast and Endocrine Surgery, Toranomon Hospital, Tokyo, Japan.
Tanaka K; Breast and Endocrine Surgery, Toranomon Hospital, Tokyo, Japan.
Kobayashi Y; Breast and Endocrine Surgery, Toranomon Hospital, Tokyo, Japan.
Sato J; Pathology, Toranomon Hospital, Tokyo, Japan.
Kinowaki K; Pathology, Toranomon Hospital, Tokyo, Japan.
Shiiba M; Diagnostic Imaging Center, Toranomon Hospital, Tokyo, Japan.
Ishihara M; Diagnostic Imaging Center, Toranomon Hospital, Tokyo, Japan.
Kawabata H; Breast and Endocrine Surgery, Toranomon Hospital, Tokyo, Japan.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 989650. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Endocrine therapy for metastatic solid pseudopapillary neoplasm of the pancreas: A case report.
Autorzy :
Kornietskaya A; P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Moscow, Russia.
Evdokimova S; P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Moscow, Russia.
Kachmazov A; P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Moscow, Russia.
Fedenko A; P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Moscow, Russia.
Bolotina L; P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Moscow, Russia.
Sidorov D; City Clinical Oncological Hospital No1, Moscow, Russia.
Volchenko N; P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Moscow, Russia.
Goeva N; P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Moscow, Russia.
Govaleshko A; P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Moscow, Russia.
Kaprin A; P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Moscow, Russia.; Peoples' Friendship University of Russia, Moscow, Russia.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 970142. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Case Reports
Raport
Tytuł :
Cytochrome C as a potential clinical marker for diagnosis and treatment of glioma.
Autorzy :
Rana R; Department of Research, Sir Ganga Ram Hospital, New Delhi, India.
Huirem RS; Department of Research, Sir Ganga Ram Hospital, New Delhi, India.
Kant R; Department of Research, Sir Ganga Ram Hospital, New Delhi, India.
Chauhan K; Department of Research, Sir Ganga Ram Hospital, New Delhi, India.
Sharma S; Department of Research, Sir Ganga Ram Hospital, New Delhi, India.
Yashavarddhan MH; Department of Research, Sir Ganga Ram Hospital, New Delhi, India.
Chhabra SS; Department of Neurosurgery, Sir Ganga Ram Hospital, New Delhi, India.
Acharya R; Department of Neurosurgery, Sir Ganga Ram Hospital, New Delhi, India.
Kalra SK; Department of Neurosurgery, Sir Ganga Ram Hospital, New Delhi, India.
Gupta A; Department of Neurosurgery, Sir Ganga Ram Hospital, New Delhi, India.
Jain S; Department of Histopathology, Sir Ganga Ram Hospital, New Delhi, India.
Ganguly NK; Department of Research, Sir Ganga Ram Hospital, New Delhi, India.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 960787. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Efficacy and safety of transarterial chemoembolization combining sorafenib with or without immune checkpoint inhibitors in previously treated patients with advanced hepatocellular carcinoma: A propensity score matching analysis.
Autorzy :
Yang XG; Department of Interventional Radiology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Chengdu, China.; Huaxi MR Research Center (HMRRC), Functional and molecular imaging Key Laboratory of Sichuan Province, Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Sun YY; Department of Interventional Radiology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Chengdu, China.
Wang HQ; Department of Hepato-Biliary-Pancreatic Surgery, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Chengdu, China.
Li DS; Department of Interventional Radiology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Chengdu, China.
Xu GH; Department of Interventional Radiology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Chengdu, China.
Huang XQ; Huaxi MR Research Center (HMRRC), Functional and molecular imaging Key Laboratory of Sichuan Province, Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 914385. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Editorial: Diagnostic and predictive biomarkers in testicular germ cell tumors.
Autorzy :
Lobo J; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP) (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Centre (Porto.CCC), Porto, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto/Porto Comprehensive Cancer Centre (Porto.CCC), Porto, Portugal.; Department of Pathology and Molecular Immunology, School of Medicine & Biomedical Sciences, University of Porto (ICBAS-UP), Porto, Portugal.
Leão R; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 1027363. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Case report: Pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: Not only a dasatinib-related adverse event.
Autorzy :
Pasquale R; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Bucelli C; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Bellani V; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Zappa M; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Cattaneo D; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 1012268. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Case Reports
Raport
Tytuł :
Frontiers and hotspots of F-FDG PET/CT radiomics: A bibliometric analysis of the published literature.
Autorzy :
Liu X; Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.; The First Clinical College, Zunyi Medical University, Zunyi, China.
Hu X; Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Yu X; Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.; The First Clinical College, Zunyi Medical University, Zunyi, China.
Li P; Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.; The First Clinical College, Zunyi Medical University, Zunyi, China.
Gu C; Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.; The First Clinical College, Zunyi Medical University, Zunyi, China.
Liu G; Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.; The First Clinical College, Zunyi Medical University, Zunyi, China.
Wu Y; Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Li D; Department of Obstetrics, Zunyi Hospital of Traditional Chinese Medicine, Zunyi, China.
Wang P; Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Cai J; Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 965773. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Prognostic value of micro-RNA 375, 133, 143, 145 in esophageal carcinoma: A systematic review and meta-analysis.
Autorzy :
Fang P; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Zhou J; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Li X; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Luan S; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Xiao X; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Shang Q; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Zhang H; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Yang Y; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Zeng X; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China.
Yuan Y; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 828339. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Systematic Review
Tytuł :
Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade.
Autorzy :
Lavoie JM; Department of Medical Oncology, BC Cancer - Surrey Centre, Surrey, BC, Canada.
Baichoo P; Terry Fox Laboratories, Vancouver, BC, Canada.
Chavez E; Centre for Lymphoid Cancer, BC Cancer Research Centre, Vancouver, BC, Canada.
Nappi L; Department of Medical Oncology, BC Cancer - Vancouver Centre, Vancouver, BC, Canada.; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Khalaf D; Department of Medical Oncology, BC Cancer - Vancouver Centre, Vancouver, BC, Canada.
Kollmannsberger CK; Department of Medical Oncology, BC Cancer - Vancouver Centre, Vancouver, BC, Canada.
Chi KN; Department of Medical Oncology, BC Cancer - Vancouver Centre, Vancouver, BC, Canada.
Weng A; Terry Fox Laboratories, Vancouver, BC, Canada.
Steidl C; Department of Medical Oncology, BC Cancer - Vancouver Centre, Vancouver, BC, Canada.
Eigl BJ; Department of Medical Oncology, BC Cancer - Vancouver Centre, Vancouver, BC, Canada.
Nissen M; Terry Fox Laboratories, Vancouver, BC, Canada.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 973402. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Oral microbiota in oropharyngeal cancers: Friend or foe?
Autorzy :
Nocini R; Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, Verona, Italy.
Muzio LL; Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
Gibellini D; Department of Diagnostic and Public Health, University of Verona, Verona, Italy.
Malerba G; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Milella M; Department of Medicine, University of Verona, Verona, Italy.
Chirumbolo S; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Zerman N; Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, Verona, Italy.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 948068. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Predictive factors for delayed hyponatremia after transsphenoidal surgery in patients with Rathke's cleft cysts.
Autorzy :
Lin K; Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China.; Department of Neurosurgery, 900Hospital of Joint Logistics Support Force, Fuzhou, China.
Pei Z; Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China.; Department of Neurosurgery, 900Hospital of Joint Logistics Support Force, Fuzhou, China.
Zhang Y; Department of Neurosurgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Feng T; Department of Neurosurgery, Dongfang Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Wang S; Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China.; Department of Neurosurgery, 900Hospital of Joint Logistics Support Force, Fuzhou, China.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 943666. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Governing HPV-related carcinoma using vaccines: Bottlenecks and breakthroughs.
Autorzy :
Bhattacharjee R; Department of Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Kumar L; School of Biology, Indian Institute of Science Education and Research, Thiruvananthapuram, India.
Dhasmana A; Himalayan School of Biosciences, Swami Rama Himalayan University, Dehradun, India.
Mitra T; KIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, India.
Dey A; Department of Life Sciences, Presidency University, Kolkata, West Bengal, India.
Malik S; Amity Institute of Biotechnology, Amity University Jharkhand, Ranchi, Jharkhand, India.
Kim B; Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, South Korea.
Gundamaraju R; ER Stress and Mucosal Immunology Lab, School of Health Sciences, University of Tasmania, Launceston, TAS, Australia.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 977933. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Favorable outcome of high-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with nonmetastatic osteosarcoma and low-degree necrosis.
Autorzy :
Hong KT; Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul, South Korea.
Park HJ; Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul, South Korea.
Kim BK; Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul, South Korea.
An HY; Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul, South Korea.
Choi JY; Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul, South Korea.
Cheon JE; Department of Radiology, Seoul National University College of Medicine, Seoul, South Korea.
Park SH; Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea.
Kim HS; Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul, South Korea.
Kang HJ; Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul, South Korea.; Wide River Institute of Immunology, Hongcheon, South Korea.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 978949. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Editorial: Targeting the Wnt/β-catenin signaling pathway in cancer.
Autorzy :
Patergnani S; Department of Medical Sciences, Laboratory for Technologies of Advanced Therapies, University of Ferrara, Ferrara, Italy.
Buchsbaum DJ; Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, AL, United States.
Piazza GA; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL, United States.
Pokaż więcej
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 1022174. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
The burden of prostate cancer in North Africa and Middle East, 1990-2019: Findings from the global burden of disease study.
Autorzy :
Abbasi-Kangevari M; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Saeedi Moghaddam S; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Ghamari SH; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Azangou-Khyavy M; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Malekpour MR; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Rezaei N; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Rezaei N; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Kolahi AA; Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Amini E; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.; Department of Urology, Uro-oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Mokdad AH; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, United States.; Department of Health Metrics Sciences, University of Washington, Seattle, WA, United States.
Jamshidi H; Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Naghavi M; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, United States.
Larijani B; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Farzadfar F; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Corporate Authors :
GBD 2019 NAME Prostate Cancer Collaborators
Źródło :
Frontiers in oncology [Front Oncol] 2022 Sep 13; Vol. 12, pp. 961086. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies